25.01.2024
Egnach, January 25, 2024 – After the introduction of tinniwell 2.0 with its improved features, sales are steadily increasing. The production time for individual series could be reduced significantly. This is no longer 12-18 months, but currently a maximum of one month. Product innovations can now also be implemented within series and do not require a new production cycle.
++ About Resaphene Suisse AG
Resaphene Suisse AG, based in Egnach, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016.
++ Contact for questions:
Resaphene Suisse AG
Mrs. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 714500668